ANDREA NIMENE: Open Payments
NPI 1861945610 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 10 payments from 6 companies in 2025. Trend: 2023 $644 · 2024 $400 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $110 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| ABBVIE INC. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: FARXIGA, INGREZZA, UZEDY, VRAYLAR, ABILIFY ASIMTUFII, COBENFY.
Industry payments across GA — which companies pay providers there.
